TABLE 1.
Prevalence of Antibiotic Use per Hospital
| Variable | Hospital A | Hospital B | Hospital C | Hospital D | Hospital E | Hospital F | Total |
|---|---|---|---|---|---|---|---|
| Facility type | Community-private | Teaching | Teaching | Community-private | Community-public | Community-private | … |
| Study period antibiotic use in DDD/100 PDa | NA | 81.8 | NA | 95.8 | NA | 89.7 | 86.3 |
| Study period antibiotic use in prescriptions/100 PDa,b | NA | 59.5 | 51.8 | NA | 12.3 | 52.2 | 46.6 |
| Inpatients on ABT, no. (%)c | 489 (47.6%) | 1,056 (48.5%) | 1,448 (78.3%) | 365 (46.6%) | 241 (60.9%) | 519 (65.9%) | 4,119 (60.4%) |
| LOS of analyzed cases, median (IQR), d | 8 (5–14) | 11 (5.5–26) | 21 (9–48) | 8 (5–12) | 7(4–14) | 8 (5–15) | 9 (5–18) |
| Duration of antimicrobial therapy, median (IQR), d | 4 (2–7) | 4 (2–7.5) | 7(3–13) | 3 (1–5) | 5 (3–7) | 4 (2–8) | 4.5 (3–7) |
NOTE. ABT, antibiotic therapy; DDD, defined daily dose; IQR, interquartile range; LOS, length of stay; NA, not available; PD, patient days.
Data from hospital B based on inpatient pharmacy orders summarized by antibiotic stewardship program coordinator; hospitals D and F report total patient ordering data. Three facilities (A, C, E) were unable to provide reliable aggregate data in DDD/PD because of duplicate or inaccurate entries in pharmacy order databases. Total includes only hospitals with complete information.
Inpatient admissions include acute and emergency department visits for all facilities. Data for hospitals A-C is for 2010 only (A and C sourced from state’s Office of Statewide Health Planning and Development database, B from hospital administrative report).
Two facilities (A and D) were unable to provide reliable data. In hospitals B and F, the number of prescriptions includes dose changes and adjustments as separate events. Total includes only hospitals with complete information.